The PREVAILS study, now fully enrolled, marks a critical step toward simultaneous regulatory submissions in China and Europe for the next-generation TAVR system HANGZHOU, China, July 23, 2026 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (02500.HK) today announced that patient enrollment...
Hence then, the article about venus medtech announces completion of patient enrollment in pivotal china trial for venus powerx the world s first fully recoverable self expanding dry valve tavr system was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System )
Also on site :
- Glass falls from 17th floor of SF high rise
- Rosalind Eleazar Is a Hollywood Actress Fighting to Rebuild Her Life in Chris Rock’s ‘Misty Green’ Trailer
- Godinger’s ‘Elegant’ Scalloped Crystal Serving Bowl Trio Brings the Old Money Look to Your Table for Less